Ceftaroline fosamil for community-acquired pneumonia

Affiliations

¹ College of Pharmacy, Qatar University, PO Box 2713, Doha, Qatar.
² College of Pharmacy, Qatar University, PO Box 2713, Doha, Qatar; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar. Electronic address: kjw@qu.edu.qa.

Comment

Shane Ashley Pawluk et al. Lancet Infect Dis. 2015 Sep.

. 2015 Sep;15(9):999.

doi: 10.1016/S1473-3099(15)00139-5.

¹ College of Pharmacy, Qatar University, PO Box 2713, Doha, Qatar.
² College of Pharmacy, Qatar University, PO Box 2713, Doha, Qatar; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar. Electronic address: kjw@qu.edu.qa.

No abstract available

Comment in

Ceftaroline fosamil for community-acquired pneumonia--Authors' reply.
Zhong NS, Sun T, Wilson D, Melnick D. Zhong NS, et al. Lancet Infect Dis. 2015 Sep;15(9):999-1000. doi: 10.1016/S1473-3099(15)00250-9. Lancet Infect Dis. 2015. PMID: 26333322 No abstract available.

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial.
Zhong NS, Sun T, Zhuo C, D'Souza G, Lee SH, Lan NH, Chiang CH, Wilson D, Sun F, Iaconis J, Melnick D. Zhong NS, et al. Lancet Infect Dis. 2015 Feb;15(2):161-71. doi: 10.1016/S1473-3099(14)71018-7. Epub 2014 Dec 22. Lancet Infect Dis. 2015. PMID: 25539586 Clinical Trial.